Stay updated with breaking news from Flemming ornskov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dubbed "Ozempic face," the gaunt appearance is a growing adverse effect of the weight loss drug due to a loss of facial volume, which Flemming Ornskov, the CEO of the Swiss company Galderma, wants to solve with filler. ....
Swiss skin care company Galderma posted first-quarter net sales of $1.071 billion on Wednesday, up 12.4% year on year, and confirmed it expected turnover growth of 7-10% this year. . ....